DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)
23,200
+150 (0.65%)
Nov 17, 2026, 9:35 AM KST
DongKook Pharmaceutical Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, DongKook Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ₩31,000. The average 1-year stock price forecast is 33.62% higher than the current stock price, while the lowest is ₩30,000 (+29.31%) and the highest is ₩32,000 (+37.93%).
Price Target: ₩31,000 (+33.62%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for DongKook Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 2 |
Financial Forecast
Revenue This Year
1.03T
from 926.88B
Increased by 11.60%
Revenue Next Year
1.17T
from 1.03T
Increased by 13.26%
EPS This Year
1.92K
from 1.48K
Increased by 30.14%
EPS Next Year
2.27K
from 1.92K
Increased by 18.18%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.